Nystatin

Product NDC: 17856-0811
Requested package NDC: 17856-0811-7
11-digit product format: 178560811
Labeler code: 17856
Product ID: 17856-0811_964869a5-8615-4c0d-9051-8a90a1270b88
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: NYSTATIN
Dosage form: SUSPENSION
Route: ORAL
Labeler: ATLANTIC BIOLOGICALS CORP.
Application: ANDA203621
Marketing category: ANDA
Marketing start: 2019-05-07
Marketing end: 0000-00-00
Substance: NYSTATIN
Active strength: 100000 [USP'U]/mL
Pharmacologic classes: Polyene Antifungal [EPC],Polyenes [CS]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	17856-0811	17856-0811-7	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

Observed captured status history: Rows come only from successfully parsed FDA auxiliary ZIP captures. They show the state present in that artifact, not a continuous regulatory timeline. Absence before, after, or between captures is not proof of status, and a known non-data HTTP 403 capture is preserved in backfill provenance but cannot produce a status row.

Historic NDC status page 1 of 1 · 4 matching rows.

Browse every current auxiliary row. · Browse the complete NDC auxiliary source catalog.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Archive	Snapshot	Source SHA-256
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	17856-0811	17856-0811-7	I	Inactivated by FDA	excluded / ndc_excluded.zip	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	17856-0811	17856-0811-7	I	Inactivated by FDA	excluded / ndc_excluded.zip	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0811	17856-0811-7	I	Inactivated by FDA	excluded / ndc_excluded.zip	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0811	17856-0811-7	I	Inactivated by FDA	excluded / ndc_excluded.zip	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A203621-001	NYSTATIN	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA		2016-01-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A203621-001	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A203621-001	NYSTATIN	100,000 UNITS/ML	SUSPENSION / ORAL	AA	2016-01-07	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A203621-001	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203621-001	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203621-001	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203621-001	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203621-001	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203621-001	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203621-001	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203621-001	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203621-001	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203621-001	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203621-001	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203621-001	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203621-001	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A203621-001	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203621-001	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203621-001	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203621-001	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203621-001	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A203621-001	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A203621-001	AA	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A203621-001	AA	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A203621-001	AA	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A203621-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A203621-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A203621-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A203621-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A203621-001	AA	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A203621-001	AA	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A203621-001	AA	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A203621-001	AA	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A203621-001	AA	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A203621-001	AA	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A203621-001	AA	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A203621-001	AA	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A203621-001	AA	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A203621-001	AA	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A203621-001	AA	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A203621-001	AA	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A203621-001	AA	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A203621-001	AA	1	`cb3db0bc1861…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Nystatin	NYSTATIN	PAI Holdings, LLC dba PAI Pharma	28b4e26e-206a-4e8a-abfe-774b780e91c3	2026-07-21	Adverse reactions	Exact identifier application applno (ANDA): 203621 application number: ANDA203621
Nystatin	NYSTATIN	Cardinal Health 107, LLC	d59098da-1395-49fb-9fd6-947bbbeed56f	2026-02-26	Adverse reactions	Exact identifier application applno (ANDA): 203621 application number: ANDA203621
Nystatin	NYSTATIN	Major Pharmaceuticals	17b9e33d-da9c-467a-bbc4-9e257727f19a	2026-02-23	Adverse reactions	Exact identifier application applno (ANDA): 203621 application number: ANDA203621
Nystatin	NYSTATIN	Cardinal Health 107, LLC	56aca0e2-8691-4701-beba-e2315524709f	2025-10-23	Adverse reactions	Exact identifier application applno (ANDA): 203621 application number: ANDA203621
Nystatin	NYSTATIN	PAI Holdings, LLC dba PAI Pharma	05a8b8b6-3639-47b8-b7fc-47b105f5e6f9	2024-07-16	Adverse reactions	Exact identifier application applno (ANDA): 203621 application number: ANDA203621
Nystatin	NYSTATIN	American Health Packaging	d8c251a6-d4da-4664-bff4-6868541d1178	2024-02-22	Adverse reactions	Exact identifier application applno (ANDA): 203621 application number: ANDA203621
Nystatin	NYSTATIN	A-S Medication Solutions	cc3516cd-985c-489f-b4a1-8477876c5a97	2023-10-19	Adverse reactions	Exact identifier application applno (ANDA): 203621 application number: ANDA203621
Nystatin	NYSTATIN	Pharmaceutical Associates, Inc.	31e3da10-5a7b-4bc5-8a4f-3e786b64c13a	2022-01-13	Adverse reactions	Exact identifier application applno (ANDA): 203621 application number: ANDA203621

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
e29fe634-dc25-094c-c77f-5d09c3eceb3e	Product name	5	20260107
4b7700e3-6e0e-45e5-9d22-6f754d61386e	Product name	2	20250304
e57b6340-9387-3f9a-7307-511c81791375	Product name	3	20221214
544f8e8d-6389-eeeb-9586-aa447c08dcc7	Product name	5	20210614
1629e00f-54fb-4a43-8306-b58442b23902	Product name	9	20200430
854ec07b-1cd7-a5db-235a-7aa24d3cf97a	Product name	3	20180628
19b9f4c1-15e9-edcc-4c16-f01ecfb5c549	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
17856-0811-1	2023-01-30	C162847	48780-1	f386c649-c1ab-0266-e053-dadaa90a7c1a	Nystatin Oral Suspension USP [100,000 units per mL]
17856-0811-2	2023-01-30	C162847	48780-1	f386c649-c1ab-0266-e053-dadaa90a7c1a	Nystatin Oral Suspension USP [100,000 units per mL]
17856-0811-3	2023-01-30	C162847	48780-1	f386c649-c1ab-0266-e053-dadaa90a7c1a	Nystatin Oral Suspension USP [100,000 units per mL]
17856-0811-4	2023-01-30	C162847	48780-1	f386c649-c1ab-0266-e053-dadaa90a7c1a	Nystatin Oral Suspension USP [100,000 units per mL]
17856-0811-5	2023-01-30	C162847	48780-1	f386c649-c1ab-0266-e053-dadaa90a7c1a	Nystatin Oral Suspension USP [100,000 units per mL]
17856-0811-6	2023-01-30	C162847	48780-1	f386c649-c1ab-0266-e053-dadaa90a7c1a	Nystatin Oral Suspension USP [100,000 units per mL]
17856-0811-7	2023-01-30	C162847	48780-1	f386c649-c1ab-0266-e053-dadaa90a7c1a	Nystatin Oral Suspension USP [100,000 units per mL]

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
17856-0811-1	Nystatin	0.5 mL in 1 SYRINGE	SUSPENSION	0.5	3
17856-0811-1	Nystatin	120 in 1 BOX, UNIT-DOSE	SUSPENSION	120	3
17856-0811-2	Nystatin	120 in 1 BOX, UNIT-DOSE	SUSPENSION	120	3
17856-0811-2	Nystatin	1 mL in 1 SYRINGE	SUSPENSION	1	3
17856-0811-3	Nystatin	120 in 1 BOX, UNIT-DOSE	SUSPENSION	120	3
17856-0811-3	Nystatin	2 mL in 1 SYRINGE	SUSPENSION	2	3
17856-0811-4	Nystatin	48 in 1 BOX, UNIT-DOSE	SUSPENSION	48	3
17856-0811-4	Nystatin	5 mL in 1 SYRINGE	SUSPENSION	5	3
17856-0811-5	Nystatin	5 mL in 1 CUP, UNIT-DOSE	SUSPENSION	5	3
17856-0811-5	Nystatin	72 in 1 BOX, UNIT-DOSE	SUSPENSION	72	3
17856-0811-6	Nystatin	1 mL in 1 SYRINGE	SUSPENSION	1	3
17856-0811-6	Nystatin	120 in 1 BOX, UNIT-DOSE	SUSPENSION	120	3
17856-0811-7	Nystatin	120 in 1 BOX, UNIT-DOSE	SUSPENSION	120	3
17856-0811-7	Nystatin	2 mL in 1 SYRINGE	SUSPENSION	2	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17856-0811	NYSTATIN SUSPENSION [ATLANTIC BIOLOGICALS CORP.]	3	Legacy NDC, 14 package rows	20210128_378c70ef-0fbc-4f0d-89c6-200735282fd7.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
BDF1O1C72E	NYSTATIN	1400-61-9	NYSTATIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
312055	nystatin 100,000 UNT/mL Oral Suspension	PSN	378c70ef-0fbc-4f0d-89c6-200735282fd7	3
312055	nystatin 100000 UNT/ML Oral Suspension	SCD	378c70ef-0fbc-4f0d-89c6-200735282fd7	3
312055	nystatin 100,000 UNT/ML Oral Suspension	SY	378c70ef-0fbc-4f0d-89c6-200735282fd7	3
312055	nystatin 500,000 UNT per 5 ML Oral Suspension	SY	378c70ef-0fbc-4f0d-89c6-200735282fd7	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
17856-0811-7	17856081107	120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0811-7) > 2 mL in 1 SYRINGE	120 syringe	2021-01-26	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Nystatin Oral Suspension USP [100,000 units per mL]	ATLANTIC BIOLOGICALS CORP.	2021-01-26	HUMAN PRESCRIPTION DRUG LABEL	3